Literature DB >> 2449819

The pathogenesis of tears of the retinal pigment epithelium.

E L Chuang1, A C Bird.   

Abstract

We compared drusen in the fellow eye of patients with unilateral retinal pigment epithelial tears with those in an age- and sex-matched group of patients with unilateral primary neovascular disciform lesions. In the fellow eye of patients with tears, drusen were more confluent and manifested less fluorescence on angiography than in the comparison group. These observations are in accord with the concept that Bruch's membrane represents a significant barrier to fluid flow, and that fluid beneath detached pigment epithelium is derived in part or wholely from the pigment epithelium.

Entities:  

Mesh:

Year:  1988        PMID: 2449819     DOI: 10.1016/0002-9394(88)90011-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear.

Authors:  B A Lafaut; S Aisenbrey; C Vanden Broecke; R Krott; C P Jonescu-Cuypers; S Reynders; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Acute tear of the retinal pigment epithelium.

Authors:  B C Patel; M Barondes; A M Hamilton
Journal:  Int Ophthalmol       Date:  1992-01       Impact factor: 2.031

3.  Computerised visual field deficits in tears of the retinal pigment epithelium.

Authors:  J I Maguire; W H Annesley; W L Decker; G C Brown; D H Fischer; J M Slagle
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

Review 4.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

5.  High-dose ranibizumab therapy for vascularized pigment epithelial detachment.

Authors:  C K Chan; P Abraham; D Sarraf
Journal:  Eye (Lond)       Date:  2012-05-11       Impact factor: 3.775

6.  Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).

Authors:  Clement K Chan; Atul Jain; Srinivas Sadda; Neeta Varshney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

7.  Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment.

Authors:  B Piguet; J A Wells; I B Palmvang; R Wormald; I H Chisholm; A C Bird
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

8.  Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration.

Authors:  C K Chan; P Abraham; D Sarraf; A S D Nuthi; S G Lin; C A McCannel
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

9.  [Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD].

Authors:  A Frimpong-Boateng; M A Varde; F Rüfer; A Bunse; J Roider
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

10.  Controlled trial of laser photocoagulation of pigment epithelial detachments in the elderly: 4 year review.

Authors:  M J Barondes; S Pagliarini; I H Chisholm; A M Hamilton; A C Bird
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.